119 related articles for article (PubMed ID: 9233837)
21. New Norcantharidin Analogs: Synthesis and Anticancer Activity.
Pachuta-Stec A; Szuster-Ciesielska A
Arch Pharm (Weinheim); 2015 Dec; 348(12):897-907. PubMed ID: 26548647
[TBL] [Abstract][Full Text] [Related]
22. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
[TBL] [Abstract][Full Text] [Related]
23. [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice].
Xiong W; Tang ZY; Ren ZG; Huang XY; Jia QA; Xie XY; Shen HJ
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):804-7. PubMed ID: 24447475
[TBL] [Abstract][Full Text] [Related]
24. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
25. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
26. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360
[TBL] [Abstract][Full Text] [Related]
27. Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.
Chu AC; Tsang SY; Lo EH; Fung KP
Life Sci; 2001 Dec; 70(5):591-601. PubMed ID: 11811903
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo.
Hu QY; Li JN; Song DQ; Wang YL; Bekesi G; Weisz I; Jiang JD
Int J Oncol; 2004 Nov; 25(5):1289-96. PubMed ID: 15492817
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
[TBL] [Abstract][Full Text] [Related]
31. [Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carboncyclic analogs of norcantharidin].
Fang Y; Tian SL; Li KQ; Zhao SW; Wang ZY
Yao Xue Xue Bao; 1993; 28(12):931-5. PubMed ID: 8030418
[TBL] [Abstract][Full Text] [Related]
32. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
[TBL] [Abstract][Full Text] [Related]
33. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
[TBL] [Abstract][Full Text] [Related]
34. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin plus norcantharidin alter the expression of TGF-β1/Smads signaling pathway in hepatocellular carcinoma.
Li KY; Shi CX; Huang JZ; Tang KL
Bratisl Lek Listy; 2017; 118(2):85-88. PubMed ID: 28814088
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles.
Chen SF; Lu WF; Wen ZY; Li Q; Chen JH
Pharmazie; 2012 Sep; 67(9):781-8. PubMed ID: 23016451
[TBL] [Abstract][Full Text] [Related]
37. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
Wang F; Li S; Lin J
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice.
Hann HW; Stahlhut MW; Rubin R; Maddrey WC
Cancer; 1992 Oct; 70(8):2051-6. PubMed ID: 1327484
[TBL] [Abstract][Full Text] [Related]
39. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Jiang Z; Chi J; Han B; Liu W
Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
[TBL] [Abstract][Full Text] [Related]
40. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
Fan YZ; Chen CQ; Zhao ZM; Sun W
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]